skip to Main Content

Lung Cancer KRAS Gene and Mesothelioma

Lung Cancer KRAS Gene and Mesothelioma New light has been shed into the gene responsible for non-small cell lung cancer. It is said that the new light could bring hope for mesothelioma patients. Researchers from UT Southwestern Medical Center have…

Read more

Mesothelioma News: Avastin – New Mesothelioma Guidelines

Mesothelioma News: New Mesothelioma Guidelines – July 2016  The National Comprehensive Cancer Network has changed its recommended first line treatment for unresectable pleural mesothelioma. This change is fueled by the belief that this will extend the patient survival rate greatly. The…

Read more

Mesothelioma News: CRS-207 Immunotherapy vaccine

  Mesothelioma News: CRS-207 Immunotherapy vaccine – May 2016 The immunotherapy vaccine CRS-207 is getting closer to changing the future treatment of malignant pleural mesothelioma. CRS-207 results for disease control rate were ninety seven percent (97%), when added to a…

Read more
KRAS Gene Study

Mesothelioma News: Immunogene Therapy Clinical Trials

  Mesothelioma News: Immunogene Therapy Clinical Trials – March 2016 Immunotherapy is likely to be the fourth pillar of mesothelioma treatment after chemotherapy, radiation and surgery, according to Dr. Sterman. Dr. Sterman, the director of Pulmonary Medicine at New York…

Read more

Mesothelioma News: New Clinical Trials – Tampa

  Mesothelioma News: New Mesothelioma Clinical Trials – Tampa The mesothelioma program at the Moffitt Cancer Center in Tampa, Florida opened two (2) new clinical trials. The phase II trials are made as second stage therapies. They provide options that…

Read more
Back To Top